TY - JOUR
T1 - The NeuroDevNet Autism Spectrum Disorders Demonstration Project
AU - Zwaigenbaum, Lonnie
AU - Scherer, Stephen
AU - Szatmari, Peter
AU - Fombonne, Eric
AU - Bryson, Susan E.
AU - Hyde, Krista
AU - Anognostou, Evdokia
AU - Brian, Jessica
AU - Evans, Alan
AU - Hall, Geoff
AU - Nicholas, David
AU - Roberts, Wendy
AU - Smith, Isabel
AU - Vaillancourt, Tracy
AU - Volden, Joanne
N1 - Funding Information:
Dr Zwaigenbaum is supported by the Stollery Children's Hospital Foundation Chair in Autism research and by a Health Scholar Award from the Alberta Innovates—Health Solutions. Dr Scherer is supported by the GlaxoSmithKline-Canadian Institutes of Health Research Endowed Chair in Genetics and Genomics. Dr Bryson, is supported by the Jack and Joan Craig Chair in Autism research, and Dr Szatmari by the Chedoke Health Chair in Child psychiatry. Drs Fombonne is supported by a Canada research Chairs in Child psychiatry and Dr Vaillancourt, by a Canada research Chair in children's mental health and Violence Protection. The research described in this paper is supported by the Canadian Institutes of Health Research, Autism Speaks Canada, the Sinneave Family Foundation and the University of Alberta women's and children's Research Institute, as well as NeuroDevNet, which is supported by the Networks of Centres of Excellence of Canada.
PY - 2011/3
Y1 - 2011/3
N2 - The NeuroDevNet Autism Spectrum Disorder Demonstration Project interfaces at many levels with the network's research themes and priorities. Our interdisciplinary team aims to improve understanding of genetic factors underlying vulnerability to autism spectrum disorders (ASDs) to develop better diagnostic strategies and, ultimately, to pinpoint molecular pathways relevant to developing biologically based treatments. Linking our existing longitudinal ASD cohorts with both genetics and neuroimaging studies will provide, for the first time, integrated data on how the genetic variation influences brain and behavioral development in ASD. Importantly, as our science progresses and we translate this information to the health care system, we will also educate policy makers, media, and business, so an informed society is prepared to capitalize on new genomic advances and effectively integrate these into health services for the broader community. We believe that this research has the potential to transform assessment and care for individuals with ASD.
AB - The NeuroDevNet Autism Spectrum Disorder Demonstration Project interfaces at many levels with the network's research themes and priorities. Our interdisciplinary team aims to improve understanding of genetic factors underlying vulnerability to autism spectrum disorders (ASDs) to develop better diagnostic strategies and, ultimately, to pinpoint molecular pathways relevant to developing biologically based treatments. Linking our existing longitudinal ASD cohorts with both genetics and neuroimaging studies will provide, for the first time, integrated data on how the genetic variation influences brain and behavioral development in ASD. Importantly, as our science progresses and we translate this information to the health care system, we will also educate policy makers, media, and business, so an informed society is prepared to capitalize on new genomic advances and effectively integrate these into health services for the broader community. We believe that this research has the potential to transform assessment and care for individuals with ASD.
UR - http://www.scopus.com/inward/record.url?scp=79955978066&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79955978066&partnerID=8YFLogxK
U2 - 10.1016/j.spen.2011.02.003
DO - 10.1016/j.spen.2011.02.003
M3 - Review article
C2 - 21575840
AN - SCOPUS:79955978066
SN - 1071-9091
VL - 18
SP - 40
EP - 48
JO - Seminars in pediatric neurology
JF - Seminars in pediatric neurology
IS - 1
ER -